期刊
NEUROREPORT
卷 14, 期 4, 页码 565-568出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001756-200303240-00007
关键词
CBP; histone acetyltransferase; huntingtin; Huntington's disease; PC12; polyglutamine
资金
- NINDS NIH HHS [NS34144, NS34172, NS38377, NS16375] Funding Source: Medline
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the abnormal expansion of a polyglutamine tract in the huntingtin protein. We have developed PC12 cell lines in which the expression of an N-terminal truncation of huntingtin (N63) with either wild type (23Q) or expanded polyglutamine (148Q) can be induced by the removal of doxycycline. Differentiated PC12 cells induced to express N63-148Q showed cellular toxicity reaching up to 50% at 6 days post-induction. Histone acetyltransferase (HAT) activity and global histone acetylation was significantly decreased in cells expressing truncated huntingtin with mutant but not normal huntingtin. These data suggest that altered chromatin modification via reduction in coactivator activity may cause neuronal transcriptional dysregulation and contribute to cellular toxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据